Increased CD44 immunoreactivity in the astrocytic processes was also shown in human patients with tuberous sclerosis [65] and the mouse model of Alexander disease [58], which are conditions accompanied by seizures. This evidence concerns the gene CD44 and tuberous sclerosis.